[1. Fairbrother JM, Gyles CL: Colibacillosis. In: Diseases of Swine. United Kingdom: Blackwell Publishing; 2012, 723-749.]Search in Google Scholar
[2. Marques LRM, Peiris JSM, Cryz SJ, O’Brien AD: Escherichia coli strains isolated from pigs with edema disease produce a variant of Shiga-like toxin II. FEMS Microbiol Lett 1987, 44: 33-38.10.1111/j.1574-6968.1987.tb02237.x]Search in Google Scholar
[3. Imberechts H, de Greve H, Schlicker C, Bouchet H, Pohl P, Charlier G, Bertschinger H, Wild P, Vandekerckove J, van Damme J, van Montagu M, Lintermans P: Characterization of F107 fimbriae of Escherichia coli 107/86, which cause edema disease in pigs, and nucleotides sequence of the F107 major fimbrial subunit gene, fedA. Infect Immun 1992, 60: 1963-1971.10.1128/iai.60.5.1963-1971.1992]Search in Google Scholar
[4. MacLeod DL, Gyles CL, Wilcock BP: Reproduction of edema disease of swine with purified Shiga-like toxin-II variant. Vet Pathol 1991, 28: 66-73.10.1177/030098589102800109]Search in Google Scholar
[5. Kwon D, Choi C, Jung T, Chung H-K, Kim J-P, Bae S-S, Cho W-S, Kim J, Chae C: Genotypic prevalence of the fimbrial adhesions (F4, F5, F6, F41 and F18) and toxins (LT, STa, STb and Stx2e) in Escherichia coli isolated from postweaning pigs with diarrhoea or oedema disease in Korea. Vet Rec 2002, 150: 35-37.10.1136/vr.150.2.35]Search in Google Scholar
[6. Uemura R, Sueyoshi M, Nagayoshi M, Nagatomo H: Antimicrobial susceptibilities of Shiga toxin-producing Escherichia coli isolates from pigs with edema disease in Japan. Microbiol Immunol 2003, 47: 57-61.10.1111/j.1348-0421.2003.tb02786.x]Search in Google Scholar
[7. Yang H, Chen S, White DG, Zhao S, McDermott P, Walker R, Meng J: Characterization of multiple-antimicrobial-resistance Escherichia coli isolates from diseased chickens and swine in China. J Clin Microbiol 2004, 42: 3483-3489.10.1128/JCM.42.8.3483-3489.2004]Search in Google Scholar
[8. Wierup M: The control of microbial diseases in animals: alternative to the use of antibiotics. Int J Antimicrob Agents 2000, 14: 315-319.10.1016/S0924-8579(00)00143-6]Search in Google Scholar
[9. Reid G, Friendship R: Alternatives to antibiotic use: probiotics for the gut. Anim Biotechnol 2002, 13: 97-112.10.1081/ABIO-12000577312212948]Search in Google Scholar
[10. Seyda C, Gökçen D, Mehtap Ünlü S: Detection of several virulence properties, antibiotics resistance and phylogenetic relationship in E. coli isolated originated from cow mastitis. Acta Vet-Beograd 2014, 64:413-425.10.2478/acve-2014-0039]Search in Google Scholar
[11. Kwon, D, Kim O, Chae C: Prevalence of genotypes for fimbriae and enterotoxins and of O serogroups in Escherichia coli isolated from diarrheic piglets in Korea. J Vet Diagn Invest 1999, 11: 146-151.10.1177/10406387990110020710098686]Search in Google Scholar
[12. Tagg JR, Dajani AS, Wannamaker LW: Bacteriocins of Gram-positive bacteria. Bacteriol Rev 1967, 40: 722-756.10.1128/br.40.3.722-756.1976413978791239]Search in Google Scholar
[13. Fooks LJ, Gibson GR: In vitro investigation of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiol Ecol, 2002, 39: 67-75.10.1111/j.1574-6941.2002.tb00907.x19709185]Search in Google Scholar
[14. Katarína K, Peter R, Herbert S, Martina B, Balász K: Influence of beta-glucan and vaccination against Lawsonia intracellularis on selected immune indices in weaned piglets. Acta Vet-Beograd 2014, 64:105-114.10.2478/acve-2014-0011]Search in Google Scholar
[15. Servin AL: Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004, 2: 405–440.10.1016/j.femsre.2004.01.00315374659]Search in Google Scholar